| Q24302482 | 15-Lipoxygenase-2 expression in human macrophages induces chemokine secretion and T cell migration |
| Q35586904 | A comparison of multiplex suspension array large-panel kits for profiling cytokines and chemokines in rheumatoid arthritis patients |
| Q80829973 | A matter of the heart |
| Q37365047 | A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients |
| Q35744767 | A mixture of anatase and rutile TiO₂ nanoparticles induces histamine secretion in mast cells |
| Q48712093 | A multiscale SPH particle model of the near-wall dynamics of leukocytes in flow |
| Q42530714 | A purified capsular polysaccharide markedly inhibits inflammatory response during endotoxic shock. |
| Q34137496 | A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis |
| Q33632677 | A salmon protein hydrolysate exerts lipid-independent anti-atherosclerotic activity in ApoE-deficient mice |
| Q34355117 | A systems biology approach to understanding atherosclerosis |
| Q50261941 | A three-dimensional in vitro model to demonstrate the haptotactic effect of monocyte chemoattractant protein-1 on atherosclerosis-associated monocyte migration. |
| Q35273303 | Activated human mast cells induce LOX-1-specific scavenger receptor expression in human monocyte-derived macrophages |
| Q46078051 | Activation of nicotinamide N-methyltrasferase and increased formation of 1-methylnicotinamide (MNA) in atherosclerosis |
| Q27023345 | Adaptive immunity and atherosclerosis: mouse tales in the AJP |
| Q34043933 | Adenosine blocks IFN-gamma-induced phosphorylation of STAT1 on serine 727 to reduce macrophage activation |
| Q36115323 | Adiponectin abates diabetes-induced endothelial dysfunction by suppressing oxidative stress, adhesion molecules, and inflammation in type 2 diabetic mice |
| Q28282643 | Advance of studies on anti-atherosclerosis mechanism of berberine |
| Q83435629 | Advances in imaging angiogenesis and inflammation in atherosclerosis |
| Q33763278 | An Unsettled Debate About the Potential Role of Infection in Pathogenesis of Atherosclerosis |
| Q37297560 | Analysis of gene expression profile identifies potential biomarkers for atherosclerosis |
| Q90424227 | Angiotensin II induces RAW264.7 macrophage polarization to the M1‑type through the connexin 43/NF‑κB pathway |
| Q27304270 | Anti-Inflammatory and Anti-Thrombotic Effects of the Fungal Metabolite Galiellalactone in Apolipoprotein E-Deficient Mice |
| Q95852374 | Anti-inflammatory Effects of Pelargonium endlicherianum Fenzl. Extracts in Lipopolysaccharide-stimulated Macrophages |
| Q38172461 | Antiplatelet therapy: targeting the TxA2 pathway. |
| Q35144885 | Apolipoprotein L6, induced in atherosclerotic lesions, promotes apoptosis and blocks Beclin 1-dependent autophagy in atherosclerotic cells. |
| Q39211827 | Application of multianalyte microphysiometry to characterize macrophage metabolic responses to oxidized LDL and effects of an apoA-1 mimetic |
| Q42469852 | Association between physical activity energy expenditure and inflammatory markers in sedentary overweight and obese women |
| Q37569833 | Association of ATP-Binding Cassette Transporter A1 (ABCA1)-565 C/T Gene Polymorphism with Hypoalphalipoproteinemia and Serum Lipids, IL-6 and CRP Levels |
| Q64283382 | Association of Cytomegalovirus DNA and Immunologic Markers of Cardiovascular Disease |
| Q57292002 | Association of monocyte myeloperoxidase with incident cardiovascular disease: The Atherosclerosis Risk in Communities Study |
| Q37339764 | Atherogenic lipids induce high-density lipoprotein uptake and cholesterol efflux in human macrophages by up-regulating transmembrane chemokine CXCL16 without engaging CXCL16-dependent cell adhesion |
| Q35127516 | Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculature |
| Q38423257 | Atherosclerosis and the role of immune cells |
| Q37319989 | Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings |
| Q30423324 | B cell subsets in atherosclerosis |
| Q42828040 | Bee Venom Reduces Atherosclerotic Lesion Formation via Anti-Inflammatory Mechanism |
| Q35989308 | Biosensors for immune cell analysis-A perspective |
| Q36860384 | Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice |
| Q37729330 | Blocking TLR2 activity diminishes and stabilizes advanced atherosclerotic lesions in apolipoprotein E-deficient mice |
| Q43013542 | Brain injury induces cholesterol 24-hydroxylase (Cyp46) expression in glial cells in a time-dependent manner |
| Q38644425 | Bridging the Gap between Gut Microbial Dysbiosis and Cardiovascular Diseases |
| Q37073901 | C-reactive protein induces M-CSF release and macrophage proliferation |
| Q44772121 | CD14 C260T promoter polymorphism and the risk of cerebrovascular diseases: a meta-analysis |
| Q28288474 | CD40 ligand as a potential biomarker for atherosclerotic instability |
| Q38754143 | CVD and Oxidative Stress |
| Q38487642 | Caesalpinia sappan L. ameliorates hypercholesterolemia in C57BL/6 mice and suppresses inflammatory responses in human umbilical vein endothelial cells (HUVECs) by antioxidant mechanism |
| Q37181638 | Canonical Wnt pathway signaling suppresses VCAM-1 expression by marrow stromal and hematopoietic cells |
| Q99201955 | Carcinogenesis: Failure of resolution of inflammation? |
| Q34886897 | Cardiovascular disease and the role of oral bacteria |
| Q28069923 | Cardiovascular disease and type 2 diabetes in evolutionary perspective: a critical role for helminths? |
| Q26739070 | Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers |
| Q37430831 | Cardiovascular toxicity caused by cancer treatment: strategies for early detection |
| Q64079453 | Carotid Intima-Media Thickness in Patients with Ankylosing Spondylitis: A Systematic Review and Updated Meta-Analysis |
| Q28741327 | Carotid plaque age is a feature of plaque stability inversely related to levels of plasma insulin |
| Q98465906 | Cell-derived biomimetic nanoparticles as a novel drug delivery system for atherosclerosis: predecessors and perspectives |
| Q52720528 | Cell-specific discrimination of desmosterol and desmosterol mimetics confers selective regulation of LXR and SREBP in macrophages. |
| Q58782501 | Clinical activity is an independent risk factor of ischemic heart and cerebrovascular arterial disease in patients with inflammatory bowel disease |
| Q34263376 | Co-stimulation of PAFR and CD36 is required for oxLDL-induced human macrophages activation. |
| Q59813473 | Complement Factor H and Apolipoprotein E Participate in Regulation of Inflammation in THP-1 Macrophages |
| Q39147404 | Complement Protein C1q Enhances Macrophage Foam Cell Survival and Efferocytosis. |
| Q37499216 | Complement protein C1q promotes macrophage anti-inflammatory M2-like polarization during the clearance of atherogenic lipoproteins |
| Q58760551 | Comprehensive analysis of circRNA expression pattern and circRNA-miRNA-mRNA network in the pathogenesis of atherosclerosis in rabbits |
| Q37406553 | Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis |
| Q33659872 | Constitutively active NF-kappaB triggers systemic TNFalpha-dependent inflammation and localized TNFalpha-independent inflammatory disease. |
| Q37641072 | Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention |
| Q37349958 | Cortical injury increases cholesterol 24S hydroxylase (Cyp46) levels in the rat brain. |
| Q37602210 | Cyclin-dependent kinase inhibitor drugs as potential novel anti-inflammatory and pro-resolution agents |
| Q30848049 | Data mining of atherosclerotic plaque transcriptomes predicts STAT1-dependent inflammatory signal integration in vascular disease. |
| Q34082315 | Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice |
| Q37942858 | Dendritic cells in human atherosclerosis: from circulation to atherosclerotic plaques |
| Q34830905 | Diabetes-related microvascular and macrovascular diseases in the physical therapy setting |
| Q38210156 | Diabetic foot and exercise therapy: step by step the role of rigid posture and biomechanics treatment. |
| Q51366263 | Diets high in palmitic acid (16:0), lauric and myristic acids (12:0 + 14:0), or oleic acid (18:1) do not alter postprandial or fasting plasma homocysteine and inflammatory markers in healthy Malaysian adults. |
| Q36124064 | Differential effects of estradiol on carotid artery inflammation when administered early versus late after surgical menopause |
| Q38479906 | Direct and Functional Biomarkers of Vitamin B6 Status |
| Q37677964 | Dose-Dependent Induction of an Idiotypic Cascade by Anti-Glycosaminoglycan Monoclonal Antibody in apoE-/- Mice: Association with Atheroprotection. |
| Q37344116 | Dual 12/15- and 5-lipoxygenase deficiency in macrophages alters arachidonic acid metabolism and attenuates peritonitis and atherosclerosis in ApoE knock-out mice |
| Q42134468 | Dynamic immune cell accumulation during flow-induced atherogenesis in mouse carotid artery: an expanded flow cytometry method |
| Q36591328 | EGCG prevents PCB-126-induced endothelial cell inflammation via epigenetic modifications of NF-κB target genes in human endothelial cells |
| Q37041227 | Effect of L-carnitine Supplementation on Circulating C-reactive Protein Levels: A Systematic Review and Meta-Analysis |
| Q36824759 | Effect of lysophosphatidic acid on the immune inflammatory response and the connexin 43 protein in myocardial infarction |
| Q37327098 | Effect of surgical treatment on lipid peroxidation parameters and antioxidant status in the serum of patients with peripheral arterial disease |
| Q37708122 | Effects of exercise-based cardiac rehabilitation in patients after percutaneous coronary intervention: A meta-analysis of randomized controlled trials |
| Q41760674 | Effects of isoflavone-supplemented soy yogurt on lipid parameters and atherosclerosis development in hypercholesterolemic rabbits: a randomized double-blind study |
| Q31134484 | Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus |
| Q34076011 | Endothelial dysfunction in tristetraprolin-deficient mice is not caused by enhanced tumor necrosis factor-α expression |
| Q51094405 | Endothelial long non-coding RNAs regulated by oxidized LDL. |
| Q35185322 | Enhanced CD36 scavenger receptor expression in THP-1 human monocytes in the presence of lupus plasma: linking autoimmunity and atherosclerosis |
| Q38275040 | Epidemiology, risk factors and management of cardiovascular diseases in IBD. |
| Q34066178 | Epigenetic control of CCR5 transcript levels in immune cells and modulation by small molecules inhibitors |
| Q37310578 | Epigenetics in atherosclerosis and inflammation |
| Q34361828 | Evaluation of Toll-Like receptor 2 and 4 RNA expression and the cytokine profile in postmenopausal women with metabolic syndrome |
| Q35066447 | Exendin-4 ameliorates oxidized-LDL-induced inhibition of macrophage migration in vitro via the NF-κB pathway |
| Q35159911 | Exercise training improves endothelial function via adiponectin-dependent and independent pathways in type 2 diabetic mice. |
| Q33738532 | Expanded network of inflammatory markers of atherogenesis: where are we now? |
| Q37576750 | Experimental immunotherapeutic approaches for atherosclerosis. |
| Q24653754 | Exploring the full spectrum of macrophage activation |
| Q36326906 | Exposure to coplanar PCBs induces endothelial cell inflammation through epigenetic regulation of NF-κB subunit p65. |
| Q46323475 | Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis |
| Q38901888 | Foam cell-derived 4-hydroxynonenal induces endothelial cell senescence in a TXNIP-dependent manner |
| Q37177329 | Fruit and vegetable consumption and its relation to markers of inflammation and oxidative stress in adolescents |
| Q37411784 | Functional analysis of 5-lipoxygenase promoter repeat variants |
| Q34235022 | Genes involved in systemic and arterial bed dependent atherosclerosis--Tampere Vascular study |
| Q51746575 | Genetic Variants in the Vicinity of LGALS-3 Gene and LGALS-3 mRNA Expression in Advanced Carotid Atherosclerosis: An Exploratory Study. |
| Q39216552 | Genetic and Epigenetic Regulation of CCR5 Transcription |
| Q33401966 | Genetic and other factors determining mannose-binding lectin levels in American Indians: the Strong Heart Study |
| Q35223445 | Genetical genomics of Th1 and Th2 immune response in a baboon model of atherosclerosis risk factors |
| Q35616553 | Genotype x adiposity interaction linkage analyses reveal a locus on chromosome 1 for lipoprotein-associated phospholipase A2, a marker of inflammation and oxidative stress |
| Q37716581 | HDL metabolism and activity in chronic kidney disease |
| Q37246875 | HIV protease inhibitor lopinavir-induced TNF-alpha and IL-6 expression is coupled to the unfolded protein response and ERK signaling pathways in macrophages |
| Q39392100 | HIV-1-Associated Atherosclerosis: Unraveling the Missing Link |
| Q34482615 | HIV-infection, atherosclerosis and the inflammatory pathway: candidate gene study in a Spanish HIV-infected population |
| Q84813040 | HLA class II is a factor in cardiovascular morbidity and mortality rates in patients with type 1 diabetes |
| Q37016732 | Hematological Parameters Improve Prediction of Mortality and Secondary Adverse Events in Coronary Angiography Patients: A Longitudinal Cohort Study |
| Q34611385 | Herpes virus infection is associated with vascular remodeling and pulmonary hypertension in idiopathic pulmonary fibrosis |
| Q46909789 | High Plasma Levels of Gremlin-1 and Macrophage Migration Inhibitory Factor, but Not Their Ratio, Indicate an Increased Risk for Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus. |
| Q59822020 | High fat diet induced atherosclerosis is accompanied with low colonic bacterial diversity and altered abundances that correlates with plaque size, plasma A-FABP and cholesterol: a pilot study of high fat diet and its intervention with Lactobacillus r |
| Q34253980 | High prevalence of human cytomegalovirus in carotid atherosclerotic plaques obtained from Russian patients undergoing carotid endarterectomy |
| Q37670939 | High-density lipoprotein affects antigen presentation by interfering with lipid raft: a promising anti-atherogenic strategy |
| Q38084913 | High-density lipoprotein in uremic patients: metabolism, impairment, and therapy |
| Q52542458 | History, prevalence and assessment of limited joint mobility: from stiff hand syndrome to diabetic foot ulcer prevention. |
| Q28394790 | Human monocyte-derived dendritic cells turn into foamy dendritic cells with IL-17A |
| Q53286737 | IL-15 aggravates atherosclerotic lesion development in LDL receptor deficient mice. |
| Q34025142 | IL-6 in diabetes and cardiovascular complications. |
| Q28541315 | Identification of novel regulatory cholesterol metabolite, 5-cholesten, 3β,25-diol, disulfate |
| Q39215639 | Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis |
| Q36203882 | Immune response to lipoproteins in atherosclerosis |
| Q46160198 | Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease |
| Q34739031 | Implication of plasma intermedin levels in patients who underwent first-time diagnostic coronary angiography: a single centre, cross-sectional study |
| Q35760064 | In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide |
| Q59808379 | In-DANBIRT Molecular Imaging of Inflammatory Cells in Atherosclerosis |
| Q79782031 | Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women |
| Q33318184 | Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events |
| Q37592501 | Increased levels of Porphyromonas gingivalis are associated with ischemic and hemorrhagic cerebrovascular disease in humans: an in vivo study |
| Q33904487 | Increased plasma concentrations of interleukin 35 in patients with coronary artery disease |
| Q38083555 | Inflammation and immune system interactions in atherosclerosis |
| Q37242876 | Inflammation but not endothelial dysfunction is associated with the severity of coronary artery disease in dyslipidemic subjects. |
| Q34463491 | Inflammation disrupts the LDL receptor pathway and accelerates the progression of vascular calcification in ESRD patients |
| Q35927509 | Inhibition of Interleukin-10 Signaling Induces Microbiota-dependent Chronic Colitis in Apolipoprotein E Deficient Mice |
| Q39191329 | Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice |
| Q35906619 | Innate Immune Proteins C1q and Mannan-Binding Lectin Enhance Clearance of Atherogenic Lipoproteins by Human Monocytes and Macrophages |
| Q57808577 | Interaction between tissue factor pathway inhibitor-2 gene polymorphisms and environmental factors associated with coronary atherosclerosis in a Chinese Han |
| Q41834087 | Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity |
| Q37382631 | Interleukin-22 Might Act as a Double-Edged Sword in Type 2 Diabetes and Coronary Artery Disease. |
| Q35004399 | Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma |
| Q90193376 | Invariant Natural Killer T-Cells and Total CD1d Restricted Cells Differentially Influence Lipid Metabolism and Atherosclerosis in Low Density Receptor Deficient Mice |
| Q34878509 | Investigation of the monocyte diapedesis-related LFA-1 and JAM-A gene variants in Turkish coronary heart disease patients |
| Q37833858 | Iron Homeostasis in Tissues Is Affected during Persistent Chlamydia pneumoniae Infection in Mice. |
| Q36172927 | Is Lipoprotein-Associated Phospholipase A2 a Link between Inflammation and Subclinical Atherosclerosis in Rheumatoid Arthritis? |
| Q37690728 | LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies |
| Q38128283 | LOX-1, OxLDL, and atherosclerosis |
| Q36230499 | Lack of evidence to support the association of polymorphisms within the TNFSF4 gene and coronary heart disease in a Chinese Han population |
| Q33561481 | Leukocyte Trafficking in Cardiovascular Disease: Insights from Experimental Models |
| Q35713532 | Linking immunity to atherosclerosis: implications for vascular pharmacology--a tribute to Göran K. Hansson |
| Q50094089 | Linking the sympathetic nervous system to the inflammasome: towards new therapeutics for atherosclerotic cardiovascular disease |
| Q37783424 | Lipotoxicity and Impaired High Density Lipoprotein-Mediated Reverse Cholesterol Transport in Chronic Kidney Disease |
| Q42071320 | Liver X Receptors as Therapeutic Targets for Managing Cholesterol: Implications for Atherosclerosis and Other Inflammatory Conditions |
| Q43292168 | Lysophosphatidylcholine- and MCP-1-induced chemotaxis of monocytes requires potassium channel activity |
| Q33377222 | MS/MS methodology to improve subcellular mapping of cholesterol using TOF-SIMS |
| Q90166405 | Macrophage-derived myeloid differentiation protein 2 plays an essential role in ox-LDL-induced inflammation and atherosclerosis |
| Q89965670 | Macrophage: A Potential Target on Cartilage Regeneration |
| Q37439428 | Matrix metalloproteinase 7 is associated with symptomatic lesions and adverse events in patients with carotid atherosclerosis |
| Q33566851 | Measuring neutrophil speed and directionality during chemotaxis, directly from a droplet of whole blood |
| Q58580904 | Mesenchymal Stem Cell Therapy for Ischemic Tissues |
| Q43111569 | Metabolic and monocyte-suppressing actions of fenofibrate in patients with mixed dyslipidemia and early glucose metabolism disturbances |
| Q36271765 | Metalloproteinase-9 contributes to endothelial dysfunction in atherosclerosis via protease activated receptor-1. |
| Q64063471 | MicroRNA-181a-5p and microRNA-181a-3p cooperatively restrict vascular inflammation and atherosclerosis |
| Q36281241 | MicroRNAs regulating cluster of differentiation 46 (CD46) in cardioembolic and non-cardioembolic stroke |
| Q34292781 | Microfluidic platform for measuring neutrophil chemotaxis from unprocessed whole blood |
| Q47703883 | Mitochondrial Respiration and Atherosclerosis: R-E-S-P-I-R-E. Find Out What it Means to Mϕ (and VSMC). |
| Q38162728 | Molecular MRI of atherosclerosis. |
| Q37419122 | Molecular genetics of atherosclerosis |
| Q34498697 | Molecular imaging of plaque vulnerability |
| Q34153125 | Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation |
| Q54937510 | Mortality and Low Serum Bicarbonate Level in Patients on Hemodiafiltration versus Peritoneal Dialysis. |
| Q38134246 | Myeloid cells in atherosclerosis: a delicate balance of anti-inflammatory and proinflammatory mechanisms |
| Q36005139 | Myeloid-specific Krüppel-like factor 2 inactivation increases macrophage and neutrophil adhesion and promotes atherosclerosis |
| Q37935278 | NASH and atherosclerosis are two aspects of a shared disease: central role for macrophages |
| Q92723341 | NFAT5 mediates hypertonic stress-induced atherosclerosis via activating NLRP3 inflammasome in endothelium |
| Q36503932 | Natural killer T cells are required for lipopolysaccharide-mediated enhancement of atherosclerosis in apolipoprotein E-deficient mice |
| Q47148282 | New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis. |
| Q37538879 | New insights into the effects of onion consumption on lipid mediators using a diet-induced model of hypercholesterolemia |
| Q41290955 | Niacin Suppresses Progression of Atherosclerosis by Inhibiting Vascular Inflammation and Apoptosis of Vascular Smooth Muscle Cells |
| Q28539734 | Notoginsenoside R1 attenuates atherosclerotic lesions in ApoE deficient mouse model |
| Q34982051 | Novel anti-inflammatory--pro-resolving mediators and their receptors |
| Q38032155 | Novel immune signals and atherosclerosis |
| Q28513365 | Overexpression of CCN3 inhibits inflammation and progression of atherosclerosis in apolipoprotein E-deficient mice |
| Q93126213 | Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target? |
| Q39092512 | Oxidized LDL induces alternative macrophage phenotype through activation of CD36 and PAFR. |
| Q52587771 | Oxidized LDL phagocytosis during foam cell formation in atherosclerotic plaques relies on a PLD2-CD36 functional interdependence. |
| Q42069314 | Oxidized Low-Density Lipoprotein Induces Apoptosis in Cultured Neonatal Rat Cardiomyocytes by Modulating the TLR4/NF-κB Pathway |
| Q30405926 | Oxidized low-density lipoprotein contributes to atherogenesis via co-activation of macrophages and mast cells |
| Q39502157 | PLTP regulates STAT3 and NFκB in differentiated THP1 cells and human monocyte-derived macrophages |
| Q33346650 | Performance comparison of two microarray platforms to assess differential gene expression in human monocyte and macrophage cells |
| Q24194365 | Periodontal therapy for the management of cardiovascular disease in patients with chronic periodontitis |
| Q24236140 | Periodontal therapy for the management of cardiovascular disease in patients with chronic periodontitis |
| Q47431131 | Periodontal therapy for the management of cardiovascular disease in patients with chronic periodontitis. |
| Q41087339 | Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction |
| Q33357022 | Peripheral arterial occlusive disease: global gene expression analyses suggest a major role for immune and inflammatory responses |
| Q41999642 | Peroxisome proliferator-activated receptors in the modulation of the immune/inflammatory response in atherosclerosis |
| Q35156436 | Physical activity and cognition in women with vascular conditions |
| Q38852365 | Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis |
| Q34447966 | Plaque rupture complications in murine atherosclerotic vein grafts can be prevented by TIMP-1 overexpression |
| Q36064574 | Plasmacytoid dendritic cells in atherosclerosis |
| Q28296999 | Poor oral health as a chronic, potentially modifiable dementia risk factor: review of the literature |
| Q34540921 | Porphyromonas gingivalis strain specific interactions with human coronary artery endothelial cells: a comparative study |
| Q92354721 | Post-sepsis syndrome - an evolving entity that afflicts survivors of sepsis |
| Q55270893 | Potential Immunological Links Between Psoriasis and Cardiovascular Disease. |
| Q34594807 | Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases |
| Q37122524 | Primate models in women's health: inflammation and atherogenesis in female cynomolgus macaques (Macaca fascicularis) |
| Q37734294 | Proinflammatory cytokines in heart failure: double-edged swords |
| Q38825692 | Pycnogenol attenuates atherosclerosis by regulating lipid metabolism through the TLR4-NF-κB pathway |
| Q33696583 | Quercetin intake with exercise modulates lipoprotein metabolism and reduces atherosclerosis plaque formation |
| Q34712927 | RCMV increases intimal hyperplasia by inducing inflammation, MCP-1 expression and recruitment of adventitial cells to intima |
| Q37612085 | ROS-Dependent Activation of Autophagy through the PI3K/Akt/mTOR Pathway Is Induced by Hydroxysafflor Yellow A-Sonodynamic Therapy in THP-1 Macrophages. |
| Q34963571 | Reconstituted high-density lipoprotein modulates activation of human leukocytes |
| Q46954505 | Red wine metabolites modulate NF-kappaB, activator protein-1 and cAMP response element-binding proteins in human endothelial cells. |
| Q24631052 | Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses |
| Q35551835 | Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors |
| Q36254316 | Relationship key factor of inflammation and the development of complications in the late period of myocardial infarction in patients with visceral obesity |
| Q28270638 | Resolvin D1 binds human phagocytes with evidence for proresolving receptors |
| Q83281987 | Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease |
| Q43511950 | Retrospective lifetime dietary patterns are associated with demographic and cardiovascular health variables in an older community-dwelling Australian population |
| Q42743381 | Rheumatologists, take heart! We may be doing something right |
| Q37252129 | Rho-associated coiled-coil-containing kinase 2 deficiency in bone marrow-derived cells leads to increased cholesterol efflux and decreased atherosclerosis |
| Q27002402 | Role of Helicobacter pylori infection in pathogenesis of atherosclerosis |
| Q26800202 | Role of Retinoic Acid-Metabolizing Cytochrome P450s, CYP26, in Inflammation and Cancer |
| Q37683958 | Role of acute infection in triggering acute coronary syndromes. |
| Q27003423 | Role of advanced glycation end products in cellular signaling |
| Q35536371 | Salicylate improves macrophage cholesterol homeostasis via activation of Ampk. |
| Q35747579 | Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease |
| Q91679381 | Screening and Risk Assessment of Coronary Artery Disease in Patients With Type 2 Diabetes: An Updated Review |
| Q28588228 | Selenoprotein K is required for palmitoylation of CD36 in macrophages: implications in foam cell formation and atherogenesis |
| Q37464848 | Serotonin 5-HT(2A) Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases |
| Q90679218 | Shikonin attenuates hyperhomocysteinemia-induced CD4+ T cell inflammatory activation and atherosclerosis in ApoE-/- mice by metabolic suppression |
| Q28565946 | Src-dependent STAT-3-mediated expression of monocyte chemoattractant protein-1 is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration |
| Q37575402 | Sulfation of 25-hydroxycholesterol regulates lipid metabolism, inflammatory responses, and cell proliferation |
| Q33865037 | Sulforaphane reduces vascular inflammation in mice and prevents TNF-α-induced monocyte adhesion to primary endothelial cells through interfering with the NF-κB pathway. |
| Q35620132 | Supervised exercise training counterbalances the adverse effects of insulin therapy in overweight/obese subjects with type 2 diabetes |
| Q37710533 | T Cell Deficits and Overexpression of Hepatocyte Growth Factor in Anti-inflammatory Circulating Monocytes of Middle-Aged Patients with Bipolar Disorder Characterized by a High Prevalence of the Metabolic Syndrome |
| Q37192834 | T cells in arteritis and atherosclerosis |
| Q36974273 | T-helper type 1 bias in healthy people is associated with cytomegalovirus serology and atherosclerosis: the Multi-Ethnic Study of Atherosclerosis |
| Q36359313 | TARGETING OF MACROPHAGE FOAM CELLS IN ATHEROSCLEROTIC PLAQUE USING OLIGONUCLEOTIDE-FUNCTIONALIZED NANOPARTICLES |
| Q54717063 | TLR3 and TLR4 as potential clinically biomarkers of cardiovascular risk in coronary artery disease (CAD) patients. |
| Q35364724 | TLR4/NF-κB signaling contributes to chronic unpredictable mild stress-induced atherosclerosis in ApoE-/- mice |
| Q45905403 | TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice. |
| Q33891892 | Target network differences between western drugs and Chinese herbal ingredients in treating cardiovascular disease |
| Q90533200 | Targeted inhibition of STAT3 as a potential treatment strategy for atherosclerosis |
| Q26750725 | Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease |
| Q93139190 | Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics |
| Q37578839 | The Helicobacter cinaedi antigen CAIP participates in atherosclerotic inflammation by promoting the differentiation of macrophages in foam cells |
| Q34021175 | The Relationship Between Serum Pentraxin 3 and Central Obesity in ST-Segment Elevation Myocardial Infarction Patients |
| Q57492139 | The Role of Gut Microbiota in Atherosclerosis and Hypertension |
| Q28076613 | The Roles of CD137 Signaling in Atherosclerosis |
| Q37135363 | The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting |
| Q42396872 | The activation of CD14, TLR4, and TLR2 by mmLDL induces IL-1β, IL-6, and IL-10 secretion in human monocytes and macrophages |
| Q28397401 | The effects of environmental chemicals on renal function |
| Q36806227 | The fatty acid oxidation product 15-A3t-isoprostane is a potent inhibitor of NFκB transcription and macrophage transformation |
| Q34164644 | The immune system in atherosclerosis |
| Q34372598 | The importance of GLUT3 for de novo lipogenesis in hypoxia-induced lipid loading of human macrophages |
| Q37213160 | The influence of coping with perceived racism and stress on lipid levels in African Americans |
| Q27000370 | The influence of innate and adaptive immune responses on atherosclerosis |
| Q61818129 | The microRNAs Regulating Vascular Smooth Muscle Cell Proliferation: A Minireview |
| Q33816260 | The novel association of the chemokine CCL22 with abdominal aortic aneurysm |
| Q26998829 | The role of EMMPRIN in T cell biology and immunological diseases |
| Q37050929 | The role of the vascular dendritic cell network in atherosclerosis |
| Q33656008 | The vasa vasorum in diseased and nondiseased arteries |
| Q35913344 | Therapeutic Efficacy of an ω-3-Fatty Acid-Containing 17-β Estradiol Nano-Delivery System against Experimental Atherosclerosis |
| Q28264081 | Three-dimensional migration of macrophages requires Hck for podosome organization and extracellular matrix proteolysis |
| Q41766572 | Tim-3 inhibits low-density lipoprotein-induced atherogenic responses in human umbilical vein endothelial cells |
| Q34582575 | Toll in the vessel wall--for better or worse? |
| Q36557759 | Toll-like receptors and atherosclerosis: key contributors in disease and health? |
| Q33694286 | Trapping of oxidized LDL in lysosomes of Kupffer cells is a trigger for hepatic inflammation |
| Q55092018 | Tumor Necrosis Factor-Alpha and Interleukin-6 Gene Polymorphisms in Iranian Patients with Ischemic Heart Failure. |
| Q39925266 | Ultrafine particles from diesel vehicle emissions at different driving cycles induce differential vascular pro-inflammatory responses: implication of chemical components and NF-kappaB signaling |
| Q35869044 | Ureteral Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Chronic Inflammation, and Renal Artery Atherosclerosis |
| Q92277029 | Urotensin II promotes secretion of LTB4 through 5-lipoxygenase via the UT-ROS-Akt pathway in RAW264.7 macrophages |
| Q37089091 | VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice. |
| Q46122309 | Vaccenic acid favourably alters immune function in obese JCR:LA-cp rats |
| Q37495603 | Vaccination against atherosclerosis? Induction of atheroprotective immunity |
| Q59353210 | Viral infection and atherosclerosis |
| Q37615411 | Why are well-educated Muscovites more likely to survive? Understanding the biological pathways |
| Q81241819 | [Pathogenesis of the metabolic syndrome] |
| Q57578962 | and Single Nucleotide Polymorphisms in Iranian Patients with Chronic Heart Failure |
| Q37352012 | mRNA-binding protein ZFP36 is expressed in atherosclerotic lesions and reduces inflammation in aortic endothelial cells |
| Q54439198 | miR-146a in PBMCs modulates Th1 function in patients with acute coronary syndrome. |
| Q39026612 | miR-21 attenuates lipopolysaccharide-induced lipid accumulation and inflammatory response: potential role in cerebrovascular disease |
| Q36811371 | miR181a protects against angiotensin II-induced osteopontin expression in vascular smooth muscle cells. |
| Q86757284 | oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4 |